Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Accenture
Covington
Fish and Richardson
AstraZeneca
Federal Trade Commission
McKinsey
Dow

Generated: January 22, 2019

DrugPatentWatch Database Preview

Dalteparin sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for dalteparin sodium and what is the scope of dalteparin sodium patent protection?

Dalteparin sodium is the generic ingredient in one branded drug marketed by Pfizer Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for dalteparin sodium. One supplier is listed for this compound.

Summary for dalteparin sodium
Pharmacology for dalteparin sodium
Medical Subject Heading (MeSH) Categories for dalteparin sodium
Synonyms for dalteparin sodium
CA002974
CA002975
D08PSU
D0E7MB
Fragmin
Heparin sodium salt, from porcine intestinal mucosa, IU>=100/mg
Heparinin
Lmw heparin
Logiparin (TN)
MFCD00081689
MolPort-042-652-620
Sandoparin (TN)
SC-18098

US Patents and Regulatory Information for dalteparin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer Inc FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-006 Apr 4, 2002 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer Inc FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-002 May 1, 2007 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer Inc FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-003 Mar 18, 1996 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer Inc FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-011 May 1, 2007 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for dalteparin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Inc FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-001 Dec 22, 1994 ➤ Sign Up ➤ Sign Up
Pfizer Inc FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-003 Mar 18, 1996 ➤ Sign Up ➤ Sign Up
Pfizer Inc FRAGMIN dalteparin sodium INJECTABLE;SUBCUTANEOUS 020287-004 Jan 30, 1998 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Daiichi Sankyo
McKinsey
Julphar
Deloitte
US Army
Colorcon
Farmers Insurance
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.